Titan Biotech Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2017 Mar-2016 Mar-2015
Growth matrix (%)        
Revenue growth 50.60 15.20 13.50 --
Op profit growth 151 38.90 (0.50) --
EBIT growth 151 32.60 5.70 --
Net profit growth 224 23.30 8.35 --
Profitability ratios (%)        
OPM 17 10.20 8.44 9.63
EBIT margin 15.30 9.15 7.95 8.54
Net profit margin 8.89 4.14 3.86 4.05
RoCE 21.20 11.80 11.50 --
RoNW 5.68 2.45 2.10 --
RoA 3.09 1.33 1.40 --
Per share ratios ()        
EPS 9.48 2.82 2.28 2.11
Dividend per share 1 0.75 0.75 0.75
Cash EPS 6.37 1.76 1.29 1.03
Book value per share 47.40 29.70 27.80 26.50
Valuation ratios        
P/E 4.50 16.40 15.40 13.90
P/CEPS 6.69 26.20 27.20 28.60
P/B 0.90 1.56 1.26 1.11
EV/EBIDTA 4.11 9.57 7.92 7.01
Payout (%)        
Dividend payout -- 26.60 39.60 42.90
Tax payout (26) (35) (33) (33)
Liquidity ratios        
Debtor days 41.80 42.40 49.20 --
Inventory days 97.60 88.20 88 --
Creditor days (16) (12) (14) --
Leverage ratios        
Interest coverage (5.20) (3.30) (3.70) (3.50)
Net debt / equity 0.56 0.79 0.36 0.36
Net debt / op. profit 1.63 3.39 2.03 1.89
Cost breakup ()        
Material costs (50) (62) (74) (75)
Employee costs (16) (5.50) (7.50) (6.80)
Other costs (18) (22) (9.90) (9)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2017 Mar-2016 Mar-2015
Revenue 79.40 52.70 45.80 40.30
yoy growth (%) 50.60 15.20 13.50 79
Raw materials (39) (33) (34) (30)
As % of sales 49.50 62.20 74.20 74.60
Employee costs (12) (2.90) (3.50) (2.70)
As % of sales 15.70 5.49 7.54 6.77
Other costs (14) (12) (4.50) (3.60)
As % of sales 17.80 22.10 9.85 8.96
Operating profit 13.50 5.36 3.86 3.88
OPM 17 10.20 8.44 9.63
Depreciation (1.80) (0.80) (0.80) (0.80)
Interest expense (2.30) (1.50) (1) (1)
Other income 0.45 0.28 0.55 0.40
Profit before tax 9.79 3.35 2.65 2.45
Taxes (2.60) (1.20) (0.90) (0.80)
Tax rate (26) (35) (33) (33)
Minorities and other (0.80) -- -- --
Adj. profit 6.45 2.18 1.77 1.63
Exceptional items 0.61 -- -- --
Net profit 7.07 2.18 1.77 1.63
yoy growth (%) 224 23.30 8.35 31.40
NPM 8.89 4.14 3.86 4.05
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2017 Mar-2016 Mar-2015
Profit before tax 9.79 3.35 2.65 2.45
Depreciation (1.80) (0.80) (0.80) (0.80)
Tax paid (2.60) (1.20) (0.90) (0.80)
Working capital 19.80 6.32 (6.30) --
Other operating items -- -- -- --
Operating cashflow 25.20 7.69 (5.30) --
Capital expenditure 24.50 2.40 (2.40) --
Free cash flow 49.70 10.10 (7.70) --
Equity raised 37.10 27.50 28 --
Investments (0.10) -- -- --
Debt financing/disposal 19.40 19 26.60 --
Dividends paid -- 0.58 0.70 0.70
Other items -- -- -- --
Net in cash 106 57.10 47.60 --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 8.26 8.26 7.74 7.74
Preference capital -- -- -- --
Reserves 30.90 23.90 16.60 15.30
Net worth 39.20 32.20 24.40 23
Minority interest
Debt 23.90 23.70 25.80 22.50
Deferred tax liabilities (net) 1.72 1.43 1.02 0.62
Total liabilities 67.10 58.80 52.40 47.20
Fixed assets 31.20 29 27 22.20
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) 0.48 0.38 0.26 --
Net working capital 33.60 27.40 23.80 20.80
Inventories 28 21.10 17.60 14.50
Inventory Days 129 -- -- 100
Sundry debtors 11.90 9.24 7.77 6.34
Debtor days 54.50 -- -- 43.90
Other current assets 3.12 3.30 3.22 4.88
Sundry creditors (4.40) (2.60) (1.70) (1.40)
Creditor days 20.30 -- -- 9.69
Other current liabilities (5) (3.70) (3) (3.60)
Cash 1.86 2.04 1.24 4.30
Total assets 67.10 58.80 52.30 47.20
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2020 Mar-2019 Mar-2018 Mar-2017 Mar-2016
Gross Sales 79.40 64.90 57.40 52.70 45.80
Excise Duty -- -- -- -- --
Net Sales 79.40 64.90 57.40 52.70 45.80
Other Operating Income -- -- -- -- --
Other Income 1.06 0.69 0.45 0.28 0.55
Total Income 80.50 65.60 57.80 53 46.30
Total Expenditure ** 66 56.10 50.40 47.40 41.90
PBIDT 14.50 9.55 7.42 5.64 4.41
Interest 2.34 2.29 2.39 1.48 0.99
PBDT 12.20 7.26 5.03 4.16 3.42
Depreciation 1.80 1.71 0.93 0.82 0.77
Minority Interest Before NP -- -- -- -- --
Tax 2.37 1.38 1.08 1.17 0.79
Deferred Tax 0.20 0.26 0.36 -- 0.10
Reported Profit After Tax 7.84 3.91 2.67 2.18 1.77
Minority Interest After NP 0.77 0.39 0.13 -- --
Net Profit after Minority Interest 7.07 3.52 2.54 2.18 1.77
Extra-ordinary Items 0.46 -- -- -- --
Adjusted Profit After Extra-ordinary item 6.61 3.52 2.54 2.18 1.77
EPS (Unit Curr.) 8.55 4.26 3.29 2.82 2.28
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 10 -- 7.50 7.50 7.50
Equity 8.26 8.26 7.74 7.74 7.74
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 18.30 14.70 12.90 10.70 9.64
PBDTM(%) 15.40 11.20 8.77 7.89 7.47
PATM(%) 9.87 6.02 4.65 4.13 3.87